Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Seer Inc.
SEER | US
1.97
USD0.03
1.55%
SEER | US
Loading StockChartView...
About Seer Inc.
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
1.97
Open
2.02
High
2.04
Low
1.96
Seer Inc. a life sciences company engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite an integrated solution that comprises consumables an automation instrumentation and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research and clinical trials. The company intends to sell its products for research purposes which cover academic institutions life sciences and research laboratories as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. Seer Inc. has a collaboration agreement with Oregon Health & Science University; The Broad Institute of MIT and Harvard; Discovery Life Sciences LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences Inc. and changed its name to Seer Inc. in July 2018. Seer Inc. was incorporated in 2017 and is headquartered in Redwood City California.
View LessSEER | US
Risk
52.0
Sharpe
-0.19
Luna's Score
51/100
Recommendation
Hold
Luna says (SEER | US)
What's Working
Strength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
70.6%1 month
52.0%3 months
56.5%6 months
45.7%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.33
Debt to equity
0.07
Debt to assets
0.07
Ent. to EBITDA
1.72
Ent. to rev.
0.11
PEG
-
Other Fundamentals
EBITDA
-94.34M
MarketCap
121.02M
MarketCap(USD)
121.02M
Div. yield
-
Op. margin
-882.03
Erngs. growth
-
Rev. growth
-23.40
Ret. on equity
-21.06
Short ratio
2.17
Short perc.
1.33
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.38
Range1M
0.40
Range3M
0.55
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
2.66
Price X volume
2.26M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 1.72 | 0.53 | Expensive |
| Ent. to Revenue | 0.11 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.33 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 56.45 | 72.80 | Lower Risk |
| Debt to Equity | 0.07 | -1.23 | Expensive |
| Debt to Assets | 0.07 | 0.25 | Cheaper |
| Market Cap | 121.02M | 3.66B | Emerging |
